• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

NIHR Oxford Health Biomedical Research Centre

MENUMENU
  • About
    • About
    • Management and core team
    • Our partners
    • Timeline of our key achievements
    • Core facilities
    • Work with us
    • Contact
  • Departments
    • NIHR Oxford Cognitive Health Clinical Research Facility
    • Brain Health Centre
    • Oxford Precision Psychiatry Lab (OxPPL)
    • Oxford Dementia and Ageing Research (OxDARE)
    • Treatment Resistant Depression Clinic
    • Experimental Medicine and Industry Partnership (EMIP)
  • Research Themes
    • Better Sleep
    • Brain Technologies
    • Data Science
    • Dementia
    • Depression Therapeutics
    • Flourishing & Wellbeing
    • Mental Health in Development
    • Molecular Targets
    • Pain
    • Preventing Multiple Morbidities
    • Psychological Treatments
  • COVID-19 Research
    • Overview
    • News
    • COVID-19 & clinical management of mental health issues
  • News & Events
    • News
    • Training and Events
    • Psychiatry Department Seminars
  • Patients & Public
    • About Patient and Public Involvement
    • Shape our research
    • Take part in our research
    • Resources for researchers
    • Resources for the public
    • Patient and Public Involvement Strategy
    • Young people’s involvement
  • Training Hub
You are here: Home / News / COVID-19 research / COVID-19 and psychiatric diagnosis / 20% of COVID-19 patients receive a psychiatric diagnosis within 90 days

20% of COVID-19 patients receive a psychiatric diagnosis within 90 days

10th November 2020

A new study suggests that having COVID-19 increases a person’s risk of developing psychiatric disorders, and that having a psychiatric disorder increases the chance of getting COVID-19.

Key findings from the study:

  • Almost 1 in 5 people diagnosed with COVID-19 receive a psychiatric diagnosis within the next 3 months
  • 1 in 4 of these people had not had a psychiatric diagnosis before COVID-19 
  • Patients with existing psychiatric disorders might be more likely to get COVID-19

Researchers from the NIHR Oxford Health Biomedical Research Centre and the University of Oxford, Department of Psychiatry have reported the first large-scale evidence that COVID-19 survivors are at an increased risk of psychiatric disorders. The study, published in The Lancet Psychiatry, used the TriNetX electronic health records of 69 million people in the USA including over 62,000 cases of COVID-19.

In the three months following testing positive for COVID-19, 1 in 5 survivors were found to get a diagnosis of anxiety, depression, or insomnia, for the first time. This is about twice as likely as for other groups of patients over the same period. A diagnosis of dementia may also be commoner. COVID-19 was also associated with more new psychiatric diagnoses in people who already had a history of psychiatric problems. Overall, almost 20 per cent of people received a psychiatric diagnosis within 90 days of getting COVID-19.  

 People have been worried that COVID-19 survivors will be at greater risk of mental health problems, and our findings in a large and detailed study show this to be likely. Services need to be ready to provide care, especially since our results are likely to be underestimates of the actual number of cases. We urgently need research to investigate the causes and identify new treatments.”

Paul Harrison, Professor of Psychiatry, University of Oxford, Theme Lead – NIHR Oxford Health BRC

The researchers also found that people with a pre-existing psychiatric diagnosis were 65 per cent more likely to be diagnosed with COVID-19 than those without, even when the known risk factors for COVID-19 were taken into account.  

This finding was unexpected and needs investigation. In the meantime, having a psychiatric disorder should be added to the list of risk factors for COVID-19.“

Dr Max Taquet, NIHR Academic Clinical Fellow, who conducted the analyses.

Read the full paper in The Lancet Psychiatry – Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

Media coverage of this story includes:
The Guardian www.theguardian.com/world/2020/nov/10/nearly-one-in-five-covid-patients-later-diagnosed-with-mental-illness-study
BBC News – www.bbc.co.uk/news/health-54874010
The Mirror – www.mirror.co.uk/science/covid-19-increases-your-risk-22981967
BBC Radio 4 Today – BBC Radio 4 Today programme 10/11/20 https://www.bbc.co.uk/programmes/m000p6vy at 50:30

Filed Under: COVID-19 and psychiatric diagnosis, COVID-19 research, News

Primary Sidebar

News Categories

  • News
    • Clinical Research Facility
    • COVID-19 research
      • Children, young people and family mental health
      • COVID-19 and psychiatric diagnosis
      • Online therapies and resources for clinicians
      • Patient and Public Involvement in the pandemic
      • PHOSP COVID
      • Vaccination and vaccine hesitancy
    • Research Themes
      • Better Sleep
      • Brain Technologies
      • Data Science
      • Dementia
      • Depression Therapeutics
      • Flourishing & Wellbeing
      • Mental Health in Development
      • Molecular Targets
      • Pain
      • Preventing Multiple Morbidities
      • Psychological Treatments
    • Training and Development
Tweets by OxHealthBRC
Follow @OxHealthBRC

Footer

Follow us

  • LinkedIn
  • Twitter
  • YouTube

Improving brain health: the future in mind

The National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) is a partnership between Oxford Health NHS Foundation Trust and the University of Oxford.  We are part of the Oxford Academic Health Partners.
Oxford Academic Health Partners
  • Sitemap
  • Accessibility
  • Disclaimer
  • Cookies
  • Contact

© 2023 NIHR Oxford Health Biomedical Research Centre · Log in

Cookies

This site uses cookies: See our privacy policy